Home > Insider Trading > Filing (0000899243-21-002184)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1490978	Schrodinger Inc.	SDGR	Pharmaceutical Preparations (2834)	954284541

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1797727	Cony D'cruz	C/O Schrodinger, Inc., 120 West 45Th Street, 17Th Floor New York NY 10036	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-01-13	2,800	$3.07	2,800	No	4	M	Direct
Common Stock	Disposition	2021-01-13	2,800	$89.75	0	No	4	S	Direct
Common Stock	Disposition	2021-01-13	2,000	$89.64	161,082	No	4	S	Indirect	By Cony and Pearl D'Cruz Revocable Trust dated August 20, 2019, and any amendments thereto

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	By Cony and Pearl D'Cruz Revocable Trust dated August 20, 2019, and any amendments thereto

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-01-13	2,800	$0.00	2,800	$3.07

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,079		2026-05-10	No	4	M	Direct

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.63 to $89.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.60 to $89.65, inclusive.
The option was granted on May 11, 2016 and is fully vested.